Genetic and environmental contributions to cognitive outcome in glioma

  • Research type

    Research Study

  • Full title

    Evaluating the role of pre-morbid educational attainment, socioeconomic status, and genetics on cognitive outcome variability in patients with low grade brain tumours: A student research project

  • IRAS ID

    233329

  • Contact name

    Andrew Tolmie

  • Contact email

    andrew.tolmie@ucl.ac.uk

  • Sponsor organisation

    University College London

  • Clinicaltrials.gov Identifier

    Z6364106/2017/09/17, UCL Data Protection Registration

  • Duration of Study in the UK

    4 years, 7 months, 25 days

  • Research summary

    Variability in health care outcomes is a significant challenge to modern society. Brain tumours can have profound effects on a patient’s cognition, including their memory, attention, decision-making abilities and knowledge, and thus their quality of life. A wide range of cognitive outcomes are observed in patients with brain tumours. Currently recognised influences on cognitive outcomes include the brain tumour itself, and treatment with surgery, chemotherapy and radiotherapy. However, these fail to account completely for the observed variation in cognitive outcomes. Recent data suggest a potential genetic influence on cognitive outcome variability in brain tumour patients, and other potential influences include pre-morbid socioeconomic status and educational attainment. The aim of this research project is to better understand the contribution that genetics as well as pre-morbid socioeconomic status and educational attainment have on cognitive outcomes in patients with low grade (less aggressive) brain tumours. There will be three phases: acquisition of retrospectively-collected imaging, demographic, clinical and neuropsychological data (phase I), prospective collection of data on current socioeconomic status, cognitive function, and genetics (phase II), followed by analysis and synthesis of all the data (phase III). Current treatment options for brain tumour-associated cognitive impairment are limited and lack significant evidence. Improved knowledge of the factors influencing cognitive outcomes and recovery in this population could lead to better-targeted interventions that optimise functional outcomes and quality of life.

  • REC name

    London - Camden & Kings Cross Research Ethics Committee

  • REC reference

    18/LO/0007

  • Date of REC Opinion

    5 Mar 2018

  • REC opinion

    Further Information Favourable Opinion